A new era for neuromyelitis optica spectrum disorder

被引：7

作者：

Silbermann, Elizabeth ^{[1
]}

Bourdette, Dennis ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA

来源：

LANCET | 2019年 / 394卷 / 10206期

关键词：

D O I：

10.1016/S0140-6736(19)31878-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1304 / 1305

页数：2

共 8 条

[1] Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies [J].

Chen, Ding ;

Gallagher, Sandra ;

Monson, Nancy L. ;

Herbst, Ronald ;

Wang, Yue .

JOURNAL OF CLINICAL MEDICINE, 2016, 5 (12)

[2] Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial [J].

Cree, Bruce A. C. ;

Bennett, Jeffrey L. ;

Kim, Ho Jin ;

Weinshenker, Brian G. ;

Pittock, Sean J. ;

Wingerchuk, Dean M. ;

Fujihara, Kazuo ;

Paul, Friedemann ;

Cutter, Gary R. ;

Marignier, Romain ;

Green, Ari J. ;

Aktas, Orhan ;

Hartung, Hans-Peter ;

Lublin, Fred D. ;

Drappa, Jorn ;

Barron, Gerard ;

Madani, Soraya ;

Ratchford, John N. ;

She, Dewei ;

Cimbora, Daniel ;

Katz, Eliezer ;

Shuey, Neil ;

Milanov, Ivan ;

Kaprelyan, Ara ;

Tarnev, Ivaylo ;

Haralanov, Lyubomir ;

Carruthers, Robert ;

Munoz, Mario ;

Quinones, Jairo ;

Vargas, Jose ;

Rodriguez, Jesus ;

Nytrova, Petra ;

Vachova, Marta ;

Mares, Jan ;

Haldre, Sulev ;

Gross-Paju, Katrin ;

Ziemssen, Tjalf ;

Zettl, Uwe Klaus ;

Klotz, Luisa ;

Bergh, Florian Then ;

Lau, Alexander ;

Dioszeghy, Peter ;

Satori, Maria ;

Vecsei, Laszlo ;

Achiron, Anat ;

Karni, Arnon ;

Vaknin-Dembinsky, Adi ;

Saida, Takahiko ;

Misu, Tatsuro ;

Baba, Masayuki .

LANCET, 2019, 394 (10206) :1352-1363

[3] Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders A Systematic Review and Meta-analysis [J].

Damato, Valentina ;

Evoli, Amelia ;

Iorio, Raffaele .

JAMA NEUROLOGY, 2016, 73 (11) :1342-1348

[4] B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets [J].

Forsthuber, Thomas G. ;

Cimbora, Daniel M. ;

Ratchford, John Nolan ;

Katz, Eliezer ;

Stuve, Olaf .

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11

[5] The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation [J].

Jarius, S. ;

Wildemann, B. .

JOURNAL OF NEUROLOGY, 2012, 259 (07) :1354-1357

[6] A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis [J].

Lennon, VA ;

Wingerchuk, DM ;

Kryzer, TJ ;

Pittock, SJ ;

Lucchinetti, CF ;

Fujihara, K ;

Nakashima, I ;

Weinshenker, BG .

LANCET, 2004, 364 (9451) :2106-2112

[7] Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder [J].

Pittock, S. J. ;

Berthele, A. ;

Fujihara, K. ;

Kim, H. J. ;

Levy, M. ;

Palace, J. ;

Nakashima, I. ;

Terzi, M. ;

Totolyan, N. ;

Viswanathan, S. ;

Wang, K. -C. ;

Pace, A. ;

Fujita, K. P. ;

Armstrong, R. ;

Wingerchuk, D. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07) :614-625

[8]

Yamamura T, 2019, NEUROLOGY, V92

← 1 →